SOTERA HEALTH COMPANY Repayments of Long-Term Debt
SOTERA HEALTH COMPANY (SHC) reported Repayments of Long-Term Debt of $3.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-06
- SOTERA HEALTH COMPANY repayments of long-term debt for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY repayments of long-term debt for the quarter ending 2026-03-31 was $3.56M, a 5.70% decline year-over-year.
- SOTERA HEALTH COMPANY repayments of long-term debt for the quarter ending 2025-12-31 was $3.56M, a 5.72% decline year-over-year.
- SOTERA HEALTH COMPANY repayments of long-term debt for the quarter ending 2025-09-30 was $75.00M.
- SOTERA HEALTH COMPANY repayments of long-term debt for fiscal 2025 was $86.10M, a 96.20% decline from fiscal 2024.
- SOTERA HEALTH COMPANY repayments of long-term debt for fiscal 2024 was $2.26B, a 90474.92% increase from fiscal 2023.
- SOTERA HEALTH COMPANY repayments of long-term debt for fiscal 2023 was $2.50M.
- SOTERA HEALTH COMPANY repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 3 month as first filed | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.56M 10-Q · filed 2026-08-06 | $7.12M derived: sum of 3 quarters · filed 2026-08-06 | $82.11M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $3.56M 10-Q · filed 2026-05-05 | $7.12M derived: sum of 2 quarters · filed 2026-05-05 | $82.11M derived: sum of 3 quarters · filed 2026-05-05 | $85.89M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $78.56M derived: sum of 2 quarters · filed 2026-02-24 | $82.33M derived: sum of 3 quarters · filed 2026-08-06 | $86.10M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $78.77M derived: sum of 2 quarters · filed 2026-08-06 | $82.55M 10-Q · filed 2025-11-04 | $86.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.55M 10-Q · filed 2026-08-06 | $11.32M derived: sum of 3 quarters · filed 2026-08-06 | $11.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $3.77M 10-Q · filed 2026-05-05 | $7.55M derived: sum of 2 quarters · filed 2026-05-05 | $7.55M derived: sum of 3 quarters · filed 2026-05-05 | $2.27B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.77M derived: sum of 2 quarters · filed 2026-02-24 | $2.26B derived: sum of 3 quarters · filed 2026-02-24 | $2.26B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.26B derived: sum of 2 quarters · filed 2025-11-04 | $2.26B 10-Q · filed 2025-11-04 | $2.26B derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $2.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.26B 10-Q · filed 2025-08-08 | $2.26B derived: sum of 3 quarters · filed 2026-02-24 | $2.26B derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-01 | $2.50M derived: sum of 2 quarters · filed 2026-02-24 | $3.75M derived: sum of 3 quarters · filed 2026-02-24 | $3.75M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.50M derived: sum of 2 quarters · filed 2026-02-24 | $2.50M derived: sum of 3 quarters · filed 2026-02-24 | $2.50M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.25M derived: sum of 2 quarters · filed 2024-11-05 | $1.25M 10-Q · filed 2024-11-05 | $1.25M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $200.00M 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $100.00M derived: sum of 3 quarters · filed 2024-02-27 | $100.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $100.00M derived: sum of 2 quarters · filed 2024-02-27 | $100.00M derived: sum of 3 quarters · filed 2024-02-27 | $100.00M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $100.00M derived: sum of 2 quarters · filed 2022-11-02 | $100.00M 10-Q · filed 2022-11-02 | $1.22B derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $1.12B derived: sum of 3 quarters · filed 2023-02-28 | $1.12B derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $1.12B derived: sum of 2 quarters · filed 2023-02-28 | $1.12B derived: sum of 3 quarters · filed 2023-02-28 | $1.18B derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.12B derived: sum of 2 quarters · filed 2023-02-28 | $1.18B derived: sum of 3 quarters · filed 2023-02-28 | $1.18B 10-K · filed 2023-02-28 | |
| 2020-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $60.88M derived: sum of 2 quarters · filed 2021-11-10 | $61.02M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $55.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $55.73M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $142.00K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $2.56B 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |